Background Clinical phage therapy is often delivered alongside antibiotics. However, the
phenomenon of phage-antibiotic synergy has been mostly studied in vitro. Here, we …

Increasing multidrug resistance has led to renewed interest in phage-based therapy. A
combination of the bacteriophages and antibiotics presents a promising approach …

Phage therapy is an abandoned antimicrobial therapy that has been resumed in recent
years. In this study, we mutated a lysogenic phage from Acinetobacter baumannii into a lytic …

Acinetobacter baumannii is a gram-negative, non-motile bacterium that, due to its multidrug
resistance, has become a major nosocomial pathogen. The increasing number of multidrug …

Acinetobacter baumannii (named in honor of the American bacteriologists Paul and Linda
Baumann) is a Gram-negative, multidrug-resistant (MDR) pathogen that causes nosocomial …

Multidrug-resistant bacterial pathogens are an increasing threat to public health, and lytic
bacteriophages have reemerged as a potential therapeutic option. In this work, we isolated …

Overuse of antibiotics in clinical medicine has contributed to the global spread of multidrug-
resistant bacterial pathogens, including Acinetobacter baumannii. We present a case of an …

Background/Aims: As an “ESKAPE” pathogen, Acinetobacter baumannii is one of the
leading causes of drug-resistant infections in humans. Phage therapy may be a useful …

Antimicrobial resistance (AMR) represents a major challenge to global health. This problem
is most apparent in healthcare facilities, with a comparatively small number of pathogens …

Abstract In 2016, a 68-year-old patient with a disseminated multidrug-resistant Acinetobacter
baumannii infection was successfully treated using lytic bacteriophages. Here we report the …